Sergio Navarro
Gilbert, AZNPI 1629720503
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 435 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 11.6% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,450, 3.0 times the $806 reported in 2022.
Across 435 payments — averaging $16.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Corium, LLC$815
- AbbVie$800
- Otsuka America Pharmaceutical, Inc.$752
- Tris Pharma Inc$720
- Ironshore Pharmaceuticals Inc.$569
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$556
- plus $3K from 19 others
What the payments were for
- Food & beverage$7,012100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Corium, LLC | 44 | $815 |
| AbbVie | 67 | $800 |
| Otsuka America Pharmaceutical, Inc. | 54 | $752 |
| Tris Pharma Inc | 58 | $720 |
| Ironshore Pharmaceuticals Inc. | 31 | $569 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 31 | $556 |
| Lundbeck LLC | 28 | $481 |
| Axsome Therapeutics, Inc. | 20 | $382 |
| Johnson & Johnson | 15 | $315 |
| Vanda Pharmaceuticals Inc. | 17 | $297 |
| Alkermes, Inc. | 13 | $281 |
| Collegium Pharmaceutical, Inc. | 11 | $176 |
| Merck | 8 | $173 |
| Supernus Pharmaceuticals, Inc. | 7 | $141 |
| Teva Pharmaceuticals USA, Inc. | 7 | $129 |
| Vertical Pharmaceuticals, LLC | 6 | $117 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $100 |
| Neos Therapeutics, LP | 4 | $61 |
| Bausch Health US, LLC | 2 | $31 |
| Almatica Pharma LLC | 1 | $29 |
| Sage Therapeutics, LLC | 1 | $20 |
| Alfasigma USA, Inc. | 1 | $19 |
| Idorsia Pharmaceuticals US Inc | 1 | $17 |
| Livanova USA, Inc. | 1 | $16 |
| Avion Pharmaceuticals | 1 | $16 |
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.